Robert W. Baird analyst Jeff Johnson reiterated a Hold rating on Cooper Co (NYSE:COO) on Friday, setting a price target of $423, which is approximately 7.22% below the present share price of $455.92.
Johnson expects Cooper Co to post earnings per share (EPS) of $2.39 for the third quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Strong Buy rating of shares in Cooper Co, with an average price target of $465.25.
The analysts price targets range from a high of $490 to a low of $423.
In its latest earnings report, released on 04/30/2021, the company reported a quarterly revenue of $719.5 million and a net profit of $143.2 million. The company's market cap is $22.45 billion.
According to TipRanks.com, Robert W. Baird analyst Jeff Johnson is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 31.4% and a 72.58% success rate.
The Cooper Cos, Inc. operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers. The Cooper Surgical business unit focuses on supplying women's health clinicians with market medical products and treatment options to improve the delivery of healthcare to women. The company was founded in 1958 and is headquartered in San Ramon, CA.